The presence of dmins has been observed in patients with myelodysplastic syndrome, acute myelogenous leukemia or chronic myelomonocytic leukemia, and amplification of the MYC and MLL genes is observed in almost all cases (Huh et al., 2016). The gene discussed is KMT2A; the disease is acute myeloid leukemia.